Skip to main content
    L

    Lexaria Bioscience Corp (LEXX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.11
    -0.33 (-7.43%)

    Market Cap: $9.35M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Lexaria Bioscience Corp (LEXX) Earnings: Report Dates and Results

    Updated Jul 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Lexaria Bioscience (LEXX) is expected to report earnings on Nov 26, 2026. In the quarter ended May 31, 2026, Lexaria Bioscience reported EPS of -$0.08, below the -$0.06 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    40%(8/20)
    Avg Surprise
    -10.71%

    Upcoming Estimates

    Reports Nov 26, 2026 (est.)Period ending Aug 31, 2026
    EPS Consensus-$0.92
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports Jan 11, 2027 (est.)Period ending Nov 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Next Report

    LEXX has an expected report date of Nov 26, 2026.

    Earnings History

    Of the 20 quarters below that had an estimate, LEXX beat 8, missed 10 and matched 2. The widest gap in the table came in the quarter ended May 31, 2025, when EPS landed 50.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    May 31, 2026-$0.08-$0.06-$0.06 - -$0.06-33.33%MissN/A11 up, 0 downJul 13, 2026N/A
    Feb 28, 2026-$0.06-$0.07-$0.07 - -$0.07+14.29%BeatN/A11 up, 0 downApr 13, 2026$20000
    Nov 30, 2025-$0.07-$0.13-$0.13 - -$0.13+46.15%BeatN/A11 up, 0 downJan 13, 2026N/A
    Aug 31, 2025-$0.14-$0.16-$0.18 - -$0.14+9.68%BeatN/A30 up, 0 downNov 26, 2025$174000
    May 31, 2025-$0.21-$0.14N/A-50.00%MissN/AN/A0 up, 0 downJul 14, 2025$174000
    Feb 28, 2025-$0.15-$0.16N/A+6.25%BeatN/AN/A0 up, 0 downApr 14, 2025$174000
    Nov 30, 2024-$0.16-$0.12N/A-33.33%MissN/AN/A0 up, 0 downJan 10, 2025$183923
    Aug 31, 2024-$0.15-$0.11N/A-36.36%MissN/AN/A0 up, 0 downNov 26, 2024$84000
    May 31, 2024-$0.13-$0.09-$0.13 - -$0.05-44.44%MissN/A30 up, 0 downJul 12, 2024$84000
    Feb 29, 2024-$0.06-$0.10-$0.10 - -$0.10+40.00%BeatN/A10 up, 0 downApr 9, 2024$145000
    Nov 30, 2023-$0.13-$0.11-$0.11 - -$0.11-18.18%MissN/A11 up, 0 downJan 12, 2024$151278
    Aug 31, 2023-$0.12-$0.13-$0.17 - -$0.10+7.69%BeatN/A20 up, 0 downNov 21, 2023N/A
    May 31, 2023-$0.37-$0.25N/A-48.00%MissN/AN/AN/AJul 14, 2023$77707
    Feb 28, 2023-$0.22-$0.22N/A+0.86%BeatN/AN/A0 up, 0 downApr 14, 2023$20025
    Nov 30, 2022-$0.30-$0.30N/A0.00%In lineN/AN/A0 up, 0 downJan 17, 2023$97735
    Aug 31, 2022-$0.24-$0.21N/A-14.29%MissN/AN/A0 up, 0 downNov 25, 2022$111150
    May 31, 2022-$0.41-$0.28-$0.28 - -$0.28-46.43%MissN/A10 up, 0 downJul 14, 2022$99717
    Feb 28, 2022-$0.25-$0.21N/A-19.05%Miss-327.3%10 up, 0 downApr 11, 2022$30650
    Nov 30, 2021-$0.35-$0.35N/A0.00%In lineN/AN/A0 up, 0 downJan 14, 2022$13880
    Aug 31, 2021-$0.22-$0.23-$0.23 - -$0.23+4.35%BeatN/A10 up, 0 downNov 29, 2021$31021
    May 31, 2021-$0.50N/AN/AN/AN/AN/AN/AN/AJul 15, 2021$204055
    Feb 28, 2021$0.11N/AN/AN/AN/AN/AN/AN/AApr 14, 2021$192006
    Nov 30, 2020-$0.23N/AN/AN/AN/AN/AN/AN/AJan 14, 2021$295656
    Aug 31, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AOct 15, 2020$133739
    May 31, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AJun 30, 2020$36423
    Feb 29, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AApr 3, 2020$37549
    Nov 30, 2019-$0.01N/AN/AN/AN/AN/AN/AN/AJan 8, 2020$10332
    Aug 31, 2019-$0.01N/AN/AN/AN/AN/AN/AN/ANov 14, 2019$125121
    May 31, 2019-$0.01N/AN/AN/AN/AN/AN/AN/AJul 8, 2019$59931
    Feb 28, 2019-$0.01N/AN/AN/AN/AN/AN/AN/AApr 15, 2019$15349
    Nov 30, 2018-$0.01N/AN/AN/AN/AN/AN/AN/AJan 11, 2019$22209
    Aug 31, 2018-$0.02N/AN/AN/AN/AN/AN/AN/ANov 14, 2018$96354
    May 31, 2018-$0.05N/AN/AN/AN/AN/AN/AN/AJul 13, 2018$140340
    Feb 28, 2018-$0.02N/AN/AN/AN/AN/AN/AN/AApr 12, 2018$171958
    Nov 30, 2017-$0.01N/AN/AN/AN/AN/AN/AN/AJan 12, 2018$24635
    Aug 31, 2017-$0.01N/AN/AN/AN/AN/AN/AN/ANov 27, 2017$12559
    May 31, 2017-$0.01N/AN/AN/AN/AN/AN/AN/AJul 13, 2017$29253
    Feb 28, 2017-$0.24N/AN/AN/AN/AN/AN/AN/AApr 13, 2017$12602
    Nov 30, 2016-$0.23N/AN/AN/AN/AN/AN/AN/AJan 13, 2017$9225
    Aug 31, 2016-$0.18N/AN/AN/AN/AN/AN/AN/ANov 28, 2016$8562
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Aug 31, 2026 was -$0.21, after -$0.66 the year before. It was -$0.49 for the year ended Aug 31, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Aug 31, 2026-$0.21N/A
    Aug 31, 2025-$0.66N/A
    Aug 31, 2024-$0.47N/A
    Aug 31, 2023-$1.01N/A
    Aug 31, 2022-$1.25N/A
    Aug 31, 2021-$0.84N/A
    Aug 31, 2020-$0.05N/A
    Aug 31, 2019-$0.04N/A
    Aug 31, 2018-$0.10N/A
    Aug 31, 2017-$0.49N/A

    Frequently Asked Questions About LEXX

    When is Lexaria Bioscience's next earnings date?

    Lexaria Bioscience's next earnings report is expected for Nov 26, 2026.

    Did LEXX beat earnings estimates last quarter?

    No. Lexaria Bioscience reported EPS of -$0.08 for the quarter ended May 31, 2026, below the -$0.06 estimate by 33.33%.

    What EPS do analysts expect from LEXX next quarter?

    The consensus EPS estimate for Lexaria Bioscience for the quarter ended Aug 31, 2026 is -$0.92 from 3 analysts.

    How often does LEXX beat earnings estimates?

    Lexaria Bioscience beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -9.58%.